Benjamin R. Yerxa

CIK: 0001145910

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IRD

Opus Genetics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

IRD
Opus Genetics, Inc.
Oct 23, 2026
Sale(S)
Direct
25.5K shares at avg. $3.53$90K
IRD
Opus Genetics, Inc.
Oct 23, 2026
Sale(S)
Direct
7.7K shares at avg. $3.55$27K
IRD
Opus Genetics, Inc.
Jul 23, 2026
Sale(S)
Direct
7.4K shares at avg. $2.97$22K
IRD
Opus Genetics, Inc.
Apr 23, 2026
Sale(S)
Direct
7.5K shares at avg. $5.24$39K
IRD
Opus Genetics, Inc.
Jan 22, 2026
Award(A)
Direct
400K shares-
IRD
Opus Genetics, Inc.
Oct 22, 2025
Tax Payment(F)
Direct
23.8K shares at avg. $1.95$46K
IRD
Opus Genetics, Inc.
Nov 21, 2024
Purchase(P)
Direct
10K shares at avg. $0.98$10K
IRD
Opus Genetics, Inc.
Nov 7, 2024
Award(A)
Direct
332.8K shares-

		Type	Shares	Price		Ownership
Oct 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	25,520	$3.53	$90,129	Direct
Oct 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	7,669	$3.55	$27,236	Direct
Jul 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	7,429	$2.97	$22,064	Direct
Apr 23, 2026	IRD Opus Genetics, Inc.	Sale(S)	7,470	$5.24	$39,121	Direct
Jan 22, 2026	IRD Opus Genetics, Inc.	Award(A)	400,000	-	$0	Direct
Oct 22, 2025	IRD Opus Genetics, Inc.	Tax Payment(F)	23,795	$1.95	$46,400	Direct
Nov 21, 2024	IRD Opus Genetics, Inc.	Purchase(P)	10,000	$0.98	$9,834	Direct
Nov 7, 2024	IRD Opus Genetics, Inc.	Award(A)	332,800	-	$0	Direct

1-8 of 8 transactions

About YERXA BENJAMIN R

YERXA BENJAMIN R (SEC CIK 0001145910) files insider reports with the SEC as President of Opus Genetics, Inc. (IRD).

Signal8 holds 8 ownership filings by YERXA BENJAMIN R (1 Form 3, 7 Form 4), filed between Oct 24, 2024 and Oct 27, 2026. Those filings report 8 transactions, from Nov 7, 2024 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on YERXA BENJAMIN R's filings is in DURHAM, NC.

Recent filings by YERXA BENJAMIN R

Oct 23, 2026: Open-market sales of IRD shares (2 lines, Form 4, code S).
Jul 23, 2026: Open-market sale of IRD shares (Form 4, code S).
Apr 23, 2026: Open-market sale of IRD shares (Form 4, code S).
Jan 22, 2026: Grant or award of IRD shares (Form 4, code A).
Oct 22, 2025: Tax withholding of IRD shares (Form 4, code F).

Other insiders filing for Opus Genetics, Inc. (IRD)

SCHACHLE JOSEPH K, Chief Operating Officer
Gagnon Robert E., Chief Financial Officer
Magrath George, Chief Executive Officer
Foundation Fighting Blindness Retinal Degeneration Fund, Director
Gallagher Cam, Director
Zaremba Rabourn Amy, Head of Fin. Quality Assurance

How to read Form 4 transaction codes